Areas of Expertise
- Administrative Law
- Copyright Law
- Drug and Device Law
- FDA Law
- Fraud and Abuse Law
- Health Law
- Intellectual Property Law
- Legislation (lobbying and government relations)
- Marijuana/Cannabis Law
- Patent Law
- Public Health Law (Bioterrorism)
- Trade Secret Law
- Vaccine Regulation (Vaccine Injury)
About Erika Lietzan
Professor Lietzan researches, writes, and teaches primarily in the areas of food and drug regulation, intellectual property, and administrative law. Some of her most recent articles have examined the history and political economy of the Hatch-Waxman (generic drug) statute, the history of and broader sociocultural context for expanded access (compassionate use) policies in the United States and France, and the costs and benefits of the new drug approval requirement. Another recent article describes an exhaustive empirical examination of new drug patent term restoration since 1984. Professor Lietzan has been an elected member of the American Law Institute since 2006, and she is an award-winning teacher at Mizzou.
Professor Lietzan brings to her scholarship and teaching eighteen years of private practice experience, eight of them as a partner in the food and drug group at Covington & Burling in Washington, DC. In practice, she handled a wide range of complex legal problems and broader legislative and regulatory policy questions affecting FDA-regulated companies. This work included lifecycle management and strategy issues, regulatory strategy and advocacy, white collar defense, congressional investigations, briefing in products liability cases, and international regulatory policy work. She was involved in every major amendment to the Federal Food, Drug, and Cosmetic Act (FDCA) between 1997 and 2014 and was deeply immersed for more than a decade in the development of the Biologics Price Competition and Innovation Act of 2010. She has been consistently identified by her peers in private practice as a “Best Lawyer in America” in the categories of FDA law (since 2013) and Biotechnology Law (since 2007).
Professor Lietzan has held one leadership position or another at the Food and Drug Law Institute (FDLI) since 2004, including a stint on its Board of Directors from 2008 to 2012. She also held leadership positions in the American Bar Association’s Section of Science and Technology Law for fourteen years.
Professor Lietzan received a bachelor’s degree from the University of North Carolina, where she graduated with honors in history. She holds a master’s degree in history from UCLA and a law degree with high honors from Duke Law School.
Latest News Featuring Erika Lietzan
- Professor Lietzan speaks at The Federalist Society’s COVID-19 & the Law Conference
- Professor Lietzan lectures at World Intellectual Property Organization summer program
- Professor Lietzan’s FDA Expertise Sought by National & International Media
- Professor Lietzan speaks to Akron law students about perils of patent reform
- Professor Lietzan continues to write about the FDA regulation of CBD products
Latest Publications from Erika Lietzan
- The “Evergreening” Metaphor in Intellectual Property Scholarship
- Distorted Drug Patents
- Access Before Evidence and the Price of FDA’s New Drug Authorities
- The Surprising Reach of FDA Regulation of Cannabis, Even after Descheduling
- The History and Political Economy of the Hatch-Waxman Amendments